The prospectus describes RBD4059, one of Ribo Life's core candidate products, as the world's first and most advanced siRNA ...

Return on Equity (ROE): Co-Diagnostics's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -18.68%, the company showcases efficient use ...

In this interview, industry expert Dr. Lohit Khera discusses the evolving role of microRNA in research, diagnostics, and ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation ...

Ludwig-Maximilians-Universität München-led researchers have induced a greater than 60% reduction in seizure frequency in a ...

A control PNA turned antimicrobial agent may help eliminate F. nucleatum, a gut microbe tied to cancer progression and ...

The treatment, which aimed to block production of a mutant protein, reduced the frequency of infant’s seizures, but did not ...

Researchers at Karolinska Institutet and Uppsala University have developed a powerful new technique to better understand how ...

Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, is proud to announce the ...

California-based Creyon Bio has announced a global licensing and multi-target research collaboration with US pharma major Eli ...

Fusobacteria, part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists are working on ...